ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986

Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer

May 17, 2013

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

June 12, 1992

NCI Resumes Clinical Education Grants

March 18, 1983

Wynder, Weinburg Head Recipients Of Milken Awards

December 14, 1990

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007